Hui Zhao

Prof. Hui Zhao


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
HLHuan Liang
Huan Liang
HXHanbin Xu
Hanbin Xu
YZYuting Zhao
Yuting Zhao
JZJing Zheng
Jing Zheng
HZHui Zhao
Hui Zhao
CLCanpeng Li
Canpeng Li

1 September 2015 in Analytica Chimica Acta
Verified
Journal Article
Closed access
XRXin Ran
Xin Ran
LYLong Yang
Long Yang
JZJianqiang Zhang
Jianqiang Zhang
GDGuogang Deng
Guogang Deng
YLYucong Li
Yucong Li
CLCanpeng Li
Canpeng Li

1 May 2017 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
GZGenfu Zhao
Genfu Zhao
LYLong Yang
Long Yang
SWShilian Wu
Shilian Wu
HZHui Zhao
Hui Zhao
ETE Tang
E Tang
CLCanpeng Li
Canpeng Li

1 October 2021 in Talanta
Verified
Journal Article
Closed access
JZJing Zheng
Jing Zheng
HZHui Zhao
Hui Zhao
GNGuobao Ning
Guobao Ning
WSWeijie Sun
Weijie Sun
LWLi Wang
Li Wang
CLCanpeng Li
Canpeng Li

8 March 2023 in Talanta
Verified
Journal Article
Closed access
HLHuifang Liu
Huifang Liu
SMSiying Ma
Siying Ma
GNGuobao Ning
Guobao Ning
RZRunlin Zhang
Runlin Zhang
HLHuan Liang
Huan Liang
HZHui Zhao
Hui Zhao

6 September 2024 in Journal of Analysis and Testing
Verified
Journal Article
Open access
PDF file
BLBilian Li
Bilian Li
MZMin Zhou
Min Zhou
CZChun Zhao
Chun Zhao
LXLin Xiao
Lin Xiao
TQTianle Qi
Tianle Qi
CLCanpeng Li
Canpeng Li
Circulating tumor cells (CTCs) are important markers for cancer. The part of tumor cells that are detached from the primary tumor or metastatic tumor and enter the blood circulation is called CTCs. It is crucial to develop a rapid, accurate, and easy-to-implement diagnostic system for CTCs for early tumor diagnosis and for monitoring progression of the disease. In this work, we reported a colorimetric and fluorescent dual-mode assay for the detection of CTCs. Our assay used magnetic nanoparticles and aptamer for CTCs capture and gold nanoparticles-loaded covalent organic frameworks (Au@COFs) for signal amplification, respectively. The magnetic nanoparticles were modified with folic acid to capture CTCs by interaction between folic acid and the folate receptor overexpressed on the surface of tumor cells. The covalent organic frameworks were engineered to have both nitro-reductase-like and glucose–oxidase-like activities. The nitro-reductase-like activity converted the substrate p-nitrophenol to p-nitroaniline for colorimetric detection, and the glucose-oxidase-like activity enabled fluorescence detection. Specifically, Au@COFs catalyzed glucose oxidation and generated hydrogen peroxide to oxidize Fe2+ to Fe3+, which converted MIL(Al)-MOF to MIL(Fe)-MOF through ion exchange, resulting in the fluorescence quenching of MIL(Al)-MOF. Our assay showed high sensitivity with a detection limit of 17 cells/mL using MCF-7 cells as model cancer cells. This work provided an efficient and ultrasensitive strategy for CTCs detection and has potential applications in cancer identification and diagnosis. Dual-mode detection system, combining colorimetric and fluorescent signals, integration of magnetic nanoparticles and aptamers for CTC capture, and utilization of covalent organic frameworks loaded with gold nanoparticles for signal amplification can improve sensitivity and accuracy.